Foto member news.jpgWe would like to provide our Healixia members the opportunity to disseminate relevant info, to provide insights in their field of expertise, and encourage members to connect.  With this website page we want to give you an overview of the publications of our Healixia members. 




Title Journal Author(s) Publication date

The African Medicines Agency: Impacts on the Continent’s Clinical Trials Regulation

Journal of Applied Clinical Trials
B. Mwizerwa Nkubito, Y. Geysels
20 June 2023

Towards a Global Implementation of eConsent in Clinical Trials

Journal of Applied Clinical Trials
L. Guffroy, H. Pieterse, D. Fauvart, Y. Geysels 
28 June 2022

Characteristics of Early Phase Clinical Trials for Rare Cancers: Insights From Interviews With Stakeholders

Frontiers in Pharmacology
M. Dooms*, R. Saesen, I. Steemans, J. Lansens and I. Huys
2 May 2022
J. Sadoff, M. Le Gars, G. Shukarev, D. Heerwegh, C. Truyers, A.M. de Groot,
J. Stoop, S. Tete, W. Van Damme, I. Leroux‑Roels, P.-J. Berghmans, M. Kimmel, P. Van Damme, J. de Hoon, W. Smith, K.E. Stephenson, S.C. De Rosa,
K.W. Cohen, M.J. McElrath, E. Cormier, G. Scheper, D.H. Barouch, J. Hendriks,
F. Struyf, M. Douoguih, J. Van Hoof, and H. Schuitemaker
13 May 2021
Gender Bias in the Clinical Evaluation of Drugs Applied Clinical Trials Younes Benjeaa, Yves Geysels 13 August 2020

As a Healixia member, we encourage you to submit recent publications as encore publications (= re-use of publications already published).

The following criteria apply:

  • At least one Healixia member is author or co-author AND
  • The publication is recently published in (national or international) peer-reviewed journal or an equivalent high level publication (e.g. thought leadership publication) AND
  • The publication is of scientific or educational interest for other Healixia members and has not a commercial purpose.

Please provide us ( a full abstract (including full author list), journal and date of publication and the link to the journal. In view of copyright regulation, only abstracts will be visible. If the article is published in Open Access, a link can be foreseen. 

Publications will be visible for a period of one year.

Healixia has the right to refuse or remove any submission; if considered inappropriate in view of above framework or in view of the general vision of Healixia.